Mycobacteria Flashcards
Pt with suspected MAC.
Which antibiotics to test susceptibility for?
Clarithromycin
Amikacin
Pt with suspected M.kansasii.
Which antibiotics to test susceptibility for?
Clarithromycin
Amikacin
Rifampicin
Patient with M.abcessus.
Which antibiotics to test susceptibility for?
clarithromycin
amikacin
cefoxitin
(also think cotrim)
Name 3 fast growing mycobacteria (<7 days)
China Absolute Fortune
M.chelonae
M.abcessus
M.fortuitum
Name 2 Intermediate-growing mycobacteria
FISH in GORGE
M.marinum
M.gordonae
Sputum from patient grew MAC clari-sensitive.
How to treat this LRTI?
MacClaREt
clarithromycin
rifampicin
ethambutol
for 12 months
(If severe MAC pulmonary disease=consider injectable amikacin/streptomycin)
How to treat pulmonary MAC (clari-resistant)?
MacIsaREt
Isoniazid/quinolone
Rifampicin
Ethambutol
Consider injectable aminoglycoside
(may use nebulised amikacin if injectable hard)
Patient with pulmonary MAC. How long to treat?
12 months since culture conversion
Rifampicin-sensitive Pulmonary M.kansasii. How to treat?
REI or REC
- Rifampicin, ethambutol, isoniazid
- Rifampicin, ethambutol, clarithromycin
Rifampicin-resistant Pulmonary M.kansasii.
How to treat?
3 drug regime guided by susceptibility
How to treat pulmonary M.malmonsae?
as per MAC.
(MACClaREt)
- clarithromycin
- Rifampicin
Ethambutol
consider injectable aminoglycoside if severe
Duration: min 12 months after culture conversion
Pulmonary M.xenopii. How to treat?
4 drug regime:
- rifampicin
- clarithromycin
- ethambutol
- isoniazid/quinolone
+ if severe, consider injectable aminoglycoside
Man listed for lung transplant but found to have NTM pulmonary disease.
Can he remain on transplant list?
Yes.
Isolation of NTM organisms including M. abscessus in potential lung transplant candidates should not preclude referral and assessment for lung transplantation.
But counsel patient about increased risk of disseminated NTM disease needing long duration on multi-antibiotic treatment.
Pulmonary M.abscessus. How to treat?
Induction phase and maintenance phase
- Induction: MIN 4 weeks iv imipenem, iv tigecycline, iv amikacin+-Po clari
(no po clari if constitutive macrolide resistance). if inducible macrolide resistance, still worth trying clari.
If constitutive macrolide resistance, just give the first 3 iv drugs.
- Maintenance: nebulised amikacin+Po clari and EITHER iv clofazimine/linezolid/ minocycline or doxycycline/moxifloxacin or ciprofloxacin/co-trimoxazole
- If constitutive macrolide resistance, then nebulised amikacin and 2 of above.
Monitoring patients on treatment for pulmonary NTM.
How to monitor?
- CT Chest at pre- and end of treatment to assess response
- send sputum every 4-12 weeks during treatment upto 12months after completing treatment to assess microbiological response
- for pts on aminoglycosides, measure levels and creatinine. do audiometry at beginning and intermittently.
- If starting ethambutol, check visual acuity and colour vision prior to starting. if patient has renal impairment, measure ethambutol levels.